NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Starlight Cardiovascular

Starlight Cardiovascular

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.starlightcardio.com/

Last Round

Grant

Sep 15, 2024

Total Funding Raised

$14.16M

Company Overview

Starlight Cardiovascular is a medical technology company that develops a portfolio of devices specifically designed to address pediatric Congenital Heart Disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

pediatric medical devicescongenital heart diseaseCHDminimally invasive surgeryneonatal cardiologycardiovascular stentspediatric microcathetermedtechinterventional cardiologyductal patencypulmonary flow restrictorclinical-stage biotechpediatric surgerymedical device innovation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Starlight Cardiovascular Comparables

Compare Starlight Cardiovascular with similar companies based on industry and business-model similarity.

Starlight Cardiovascular comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Renata Medical
89%
NuMED
84%
PolyVascular, Inc.
82%

Starlight Cardiovascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 15, 2024
GrantMay 1, 2024
GrantMar 22, 2023
Series AOct 4, 2022
SeedJul 1, 2021
Accelerator
Mar 26, 2021

Key People

Founding team and executive leadership

Beverly Tang

Chief Executive Officer

Executive Team

Starlight Cardiovascular Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 6, 2025

    Monthly visitors grew 2909% MoM, from 22 to 662.

  • Aug 24, 2025

    Grew 27% QoQ from 11 to 14 employees.

Starlight Cardiovascular Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Starlight Cardiovascular Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Starlight Cardiovascular's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range12
Year Founded2020
Last FundingSep 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.